Skip to content
Subscriber Only

Drug Industry’s Covid-19 Push Didn’t Cross Over to Other Viruses

Even as drugmakers mounted an unprecedented response to Covid-19 last year, they continued to ignore other viruses that mostly affect poorer countries, a report found.

The pipeline of potential drugs and vaccines against the new coronavirus went from zero to 63 projects through June 2020, according to the Access to Medicine Foundation, which reviews 20 of the world’s biggest drugmakers. Meanwhile, none of the companies was working on 10 of 16 other emerging infectious diseases flagged by the World Health Organization as a risk of pandemic or serious epidemic.